Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Plenary Session 2: Targeting the Epigenome of DLBCL

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Plenary Session 2: Targeting the Epigenome of DLBCL
DNA and histone methylation as therapeutic targets in lymphoma
Ari M Melnick
Weill Cornell Medical College, New York, NY, United States
from 2018 Advances in Malignant Lymphoma conference on June 23, 2018 2:00 PM-4:00 PM
Plenary Session 2: Targeting the Epigenome of DLBCL
Targeting EZH2 in lymphoma
Vincent Ribrag
Institut Gustave-Roussy, Villejuif, France
from 2018 Advances in Malignant Lymphoma conference on June 23, 2018 2:00 PM-4:00 PM
Plenary Session 2: Targeting the Epigenome of DLBCL
  •  
  • Permission not
    granted for presentation
  •  
  •  
Germinal center-derived lymphomas: At the intersection of genetics and epigenetics
Laura Pasqualucci
Columbia University Institute for Cancer Genetics, New York, NY, United States
from 2018 Advances in Malignant Lymphoma conference on June 23, 2018 2:00 PM-4:00 PM
Plenary Session 2: Targeting the Epigenome of DLBCL
BET inhibitors in lymphoma
Francesco Bertoni
Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland
from 2018 Advances in Malignant Lymphoma conference on June 23, 2018 2:00 PM-4:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4